1. Home
  2. PLSM vs PLUR Comparison

PLSM vs PLUR Comparison

Compare PLSM & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$2.22

Market Cap

15.7M

Sector

Health Care

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$1.08

Market Cap

18.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSM
PLUR
Founded
2014
2001
Country
Israel
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
18.5M
IPO Year
2025
2001

Fundamental Metrics

Financial Performance
Metric
PLSM
PLUR
Price
$2.22
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
44.8K
24.5K
Earning Date
03-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
N/A
$1,016,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.26
$1.06
52 Week High
$12.97
$4.87

Technical Indicators

Market Signals
Indicator
PLSM
PLUR
Relative Strength Index (RSI) 31.47 32.26
Support Level N/A N/A
Resistance Level $2.88 $1.85
Average True Range (ATR) 0.24 0.12
MACD 0.02 -0.02
Stochastic Oscillator 19.35 10.80

Price Performance

Historical Comparison
PLSM
PLUR

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: